Literature DB >> 12458045

Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain.

Ron Strohmeyer1, Mauricio Ramirez, Gregory J Cole, Kyle Mueller, Joseph Rogers.   

Abstract

Factor H, a regulatory protein of the alternative pathway of complement (APC), is present in amyloid-beta (Abeta) plaques in Alzheimer's disease (AD). Abeta plaques also contain significant amounts of heparan sulfate proteoglycans (HSPGs), such as agrin, as well as numerous activated microglia expressing increased levels complement receptor 3 (CR3). Here, we show the colocalization of each of these molecules in the AD brain and the functional capacity for these molecules to bind to one another in vitro. We propose that CR3 receptors expressed by microglia are used for ligand binding to factor H bound to HSPGs and Abeta in plaques in the AD brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458045     DOI: 10.1016/s0165-5728(02)00272-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  39 in total

Review 1.  Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.

Authors:  Peng Li; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2010-08-11       Impact factor: 4.742

Review 2.  Microglial dysfunction in brain aging and Alzheimer's disease.

Authors:  Kira Irving Mosher; Tony Wyss-Coray
Journal:  Biochem Pharmacol       Date:  2014-01-18       Impact factor: 5.858

3.  Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia.

Authors:  Hongjun Fu; Bin Liu; Jeffrey L Frost; Soyon Hong; Ming Jin; Beth Ostaszewski; Ganesh M Shankar; Isabel M Costantino; Michael C Carroll; Tanya N Mayadas; Cynthia A Lemere
Journal:  Glia       Date:  2012-03-21       Impact factor: 7.452

4.  c-Jun and c-Fos regulate the complement factor H promoter in murine astrocytes.

Authors:  Laura A Fraczek; Carol B Martin; Brian K Martin
Journal:  Mol Immunol       Date:  2011-09-14       Impact factor: 4.407

Review 5.  Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).

Authors:  Hema L Ramkumar; Jun Zhang; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2010-03-03       Impact factor: 21.198

6.  Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease.

Authors:  Gillian Hamilton; Petra Proitsi; Julie Williams; Michael O'Donovan; Michael Owen; John Powell; Simon Lovestone
Journal:  Neuromolecular Med       Date:  2007-09-22       Impact factor: 3.843

7.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

8.  CSF Biomarkers for Alzheimer's Disease Diagnosis.

Authors:  A Anoop; Pradeep K Singh; Reeba S Jacob; Samir K Maji
Journal:  Int J Alzheimers Dis       Date:  2010-06-23

Review 9.  Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Authors:  Christopher D Aluise; Renã A Sowell; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2008-08-07

10.  CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease.

Authors:  Deng-Feng Zhang; Jin Li; Huan Wu; Yue Cui; Rui Bi; He-Jiang Zhou; Hui-Zhen Wang; Chen Zhang; Dong Wang; Qing-Peng Kong; Tao Li; Yiru Fang; Tianzi Jiang; Yong-Gang Yao
Journal:  Neuropsychopharmacology       Date:  2015-08-05       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.